Literature meta-analysis about the efficacy of re-challenge with PD-1 and PD-L1 inhibitors in cancer patients.
Bull Cancer
; 107(11): 1098-1107, 2020 Nov.
Article
in En
| MEDLINE
| ID: mdl-33032816
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
B7-H1 Antigen
/
Programmed Cell Death 1 Receptor
/
Antineoplastic Agents, Immunological
/
Neoplasms
Type of study:
Guideline
/
Systematic_reviews
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Bull Cancer
Year:
2020
Document type:
Article
Country of publication:
Francia